Showing results (601-610 of 658) with videos related to

Sort By:
Pageof 66
Journal of Immunology Research|July 8, 2026
Dynamics of Circulating Follicular Helper and Regulatory T-Cell Memory Induced by mRNA, Inactivated, and Live-Attenuated VaccinesA China, A Rahman, L Hani, et al.
The Journal of Experimental Medicine|March 1, 1995
Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosusL Llorente, W Zou, Y Levy, et al.
Acta Diabetologica|September 17, 2014
The use of continuous glucose monitoring systems in a pediatric population with type 1 diabetes mellitus in real-life settings: the AWeSoMe Study Group experienceM Rachmiel, Z Landau, M Boaz, et al.
Environment International|March 13, 2018
Comparison of radiofrequency electromagnetic field exposure levels in different everyday microenvironments in an international contextSanjay Sagar, Seid M Adem, Benjamin Struchen, et al.
Anesthesia and Analgesia|May 13, 1999
Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Hextend Study GroupT J Gan, E Bennett-Guerrero, B Phillips-Bute, et al.
The Annals of Thoracic Surgery|February 5, 2004
Predictors of transfusion requirements for cardiac surgical procedures at a blood conservation centerDavid M Moskowitz, James J Klein, Aryeh Shander, et al.
British Journal of Haematology|July 21, 2022
A phase 2, multicentre, open-label trial (ACE-LY-003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphomaPaolo Strati, Morton Coleman, Rebecca Champion, et al.
Nature Biotechnology|December 4, 2001
Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cellsJ W Bulte, T Douglas, B Witwer, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2011
PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patientsSamuel M Moskowitz, Mark K Brannon, Nandini Dasgupta, et al.
ERJ Open Research|June 21, 2019
Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del allelesJennifer L Taylor-Cousar, Marcus A Mall, Bonnie W Ramsey, et al.
Pageof 66